Search for: "Amylin Pharmaceuticals, Inc."
Results 21 - 40
of 51
Sorted by Relevance
|
Sort by Date
19 Apr 2013, 9:32 am
Amylin Pharmaceuticals, confirm that corporations, as a matter of process, should carefully consider and review whether proxy put and other similar change-of- control provisions in credit agreements and indentures are truly in the best interests of the stockholders. [read post]
24 May 2012, 6:15 am
Amylin Pharmaceuticals, Inc. [1] granting a motion to expedite a claim by Carl Icahn that Amylin's directors breached their fiduciary duties by not waiving Amylin's advance notice bylaw. [read post]
8 Nov 2007, 9:11 am
The comments are in on the PTO's proposed BPAI rule changes - they are not favorable.Comments from Intellectual Property Organizations and Government Agencies:(1) American Bar Association (ABA)(2) American Intellectual Property Law Association (AIPLA)(3) Bar Association District Columbia (BADC)(4) Intellectual Property Owners Association (IPO)(5) Intellectual Ventures (IV)(6) Minnesota Intellectual Property Law Association (MIPLA)(7) National Association of Patent Practitioners (NAPP)(8)… [read post]
12 Jul 2011, 6:59 am
In 2002, Lilly entered a collaboration agreement with Plaintiff Amylin Pharmaceuticals to sell Amylin’s type-2 diabetes treatment Byetta. [read post]
6 Nov 2009, 8:14 am
Byetta, made by Amylin Pharmaceuticals Inc. of San Diego, is used to control blood sugar levels in Type II diabetes patients already using diet, exercise and some other diabetes medications. [read post]
7 Aug 2012, 8:10 am
Ramnarine made more than $300,000 in illegal profits by misusing nonpublic information he obtained while helping Bristol-Myers Squibb evaluate whether to acquire three other pharmaceutical companies (Pharmasset Inc., Amylin Pharmaceuticals Inc., and ZymoGenetics Inc.). [read post]
17 Oct 2007, 3:26 am
FDA has asked and the maker of Byetta, Amylin Pharmaceuticals, Inc. has agreed to include information about acute pancreatitis in the PRECAUTIONS section of the product label. [read post]
4 Sep 2012, 7:31 am
But as she prepared to woo drug maker Amylin Pharmaceuticals Inc. last year, she was worried. [read post]
6 Jan 2010, 2:05 pm
FDA Letter About Byetta Sent To Amilyn In October 2009; Drug Company Tries To Downplay, But Investors React When They Learn About It In December 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) On October 30, 2009 Amylin Pharmaceuticals Inc. issued a press release, "BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes Prescribing Information Also Includes Updated Safety Information", in which they announced that the FDA had approved an… [read post]
18 Aug 2008, 9:24 pm
For your convenience, we provide these additional resources: The January 2008 revised Byetta package insert, or label, for Byetta from Amylin Pharmaceuticals, Inc.; and, The October 2007 so-called "Dear Doctor" letter about Byetta from Amylin Pharmaceuticals, Inc. and Eli Lilly and Company. [read post]
3 Nov 2009, 2:35 pm
On November 2, 2009 Amylin Pharmaceuticals, Inc., and Eli Lilly and Company issued their joint statement in response to the FDA on BYETTA® (exenatide) injection. [read post]
13 Sep 2008, 1:09 pm
FDA is working with the maker of Byetta, Amylin Pharmaceuticals, Inc., to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis If you believe you have a case and have sustained injuries from taking Byetta, first, do not stop taking your medication. [read post]
19 Oct 2007, 5:14 am
According to an October 17, 2007 article, "FDA Says Diabetes Drug May Cause Pancreatitis", by Jennifer Corbett Dooren:Byetta is co-marketed by Amylin Pharmaceuticals Inc., based in San Diego, and Eli Lilly & Co., of Indianapolis. [read post]
5 Nov 2009, 1:12 pm
Despite numerous claims of patients diagnosed with pancreatitis who have taken Byetta, including several deaths, neither the FDA or the drug manufacturer, Amylin Pharmaceuticals, have announced plans to issue a Byetta recall. [read post]
24 Sep 2010, 1:22 pm
Patent No. 7,297,761 owned by Amylin Pharmaceuticals, Inc. and entitled PHARMACEUTICAL COMPOSITIONS CONTAINING EXENDINS. [read post]
8 Nov 2007, 9:50 am
[PDF] Amylin Pharmaceuticals, Inc. [read post]
3 Nov 2009, 11:00 am
Byetta is manufactured by San Diego-based Amylin Pharmaceuticals Inc [read post]
16 Oct 2008, 8:19 pm
We had previously written a blog about Byetta developed by Eli Lilly and Company and Amylin Pharmaceuticals, Inc. [read post]
19 Apr 2009, 12:37 pm
This is currently the case with Amylin Pharmaceuticals, Inc., which has received notices of nominations of short slates from both Eastbourne Capital Management L.L.C. and funds affiliated with Carl Icahn. [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
